Zobrazeno 1 - 10
of 35
pro vyhledávání: '"G, Drudi"'
Autor:
M.E. Cazzaniga, G. Pinotti, E. Montagna, D. Amoroso, R. Berardi, A. Butera, K. Cagossi, L. Cavanna, M. Ciccarese, S. Cinieri, E. Cretella, E. De Conciliis, A. Febbraro, F. Ferraù, A. Ferzi, G. Fiorentini, A. Fontana, A.R. Gambaro, O. Garrone, V. Gebbia, D. Generali, L. Gianni, F. Giovanardi, A. Grassadonia, V. Leonardi, P. Marchetti, E. Melegari, A. Musolino, M. Nicolini, C. Putzu, F. Riccardi, D. Santini, S. Saracchini, M.G. Sarobba, M.G. Schintu, G. Scognamiglio, P. Spadaro, C. Taverniti, D. Toniolo, P. Tralongo, A. Turletti, R. Valenza, M.R. Valerio, P. Vici, L. Clivio, V. Torri, F. Cicchiello, F. Riva, I. Vallini, M. Mazza, C. Bonfadini, E. Bordin, M. Canicattì, F. Cappuccio, E. Collovà, C. De Angelis, R. Desorte, S. Donati, G. Drudi, D. Galanti, C. Mocerino, L. Orlando, B. Pellegrino, L. Pizzuti, C. Ridolfi, A. Rocca, D. Sarti, I. Spagnoletti, N. Tinari, A. Vandone, L. Vizzini
Publikováno v:
The Breast. 48:7-16
Metronomic chemotherapy (mCHT) refers to the minimum biologically effective dose of a chemotherapy agent given as a continuous dosing regimen, with no prolonged drug-free breaks, that leads to antitumor activity. Aim of the present study is to descri
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Emiliano Tamburini, P. Fabbri, G. Drudi, A. Polselli, M. Nicolini, E. Barzotti, B. Venturini, Valentina Arcangeli, Davide Tassinari
Publikováno v:
European Journal of Cancer. 51:S458-S459
Autor:
Maximilian Papi, G. Drudi, E. Pasquini, Ilaria Panzini, A. Polselli, Pier Paolo Fattori, A. Masi, Alberto Ravaioli, F. Alessandrini, Giuseppe Pasini, Debora Canuti, Davide Tassinari
Publikováno v:
Annals of Oncology. 9:1173-1177
Bone scan (BS), chest X-rays (CXR), liver ultrasonography (LUS) and laboratory parameters (LP) are frequently used as routine staging procedures for breast cancer patients. These procedures are not always appropriate in either clinical or research se
Autor:
Davide Tassinari, Ilaria Panzini, S. Sartori, Alberto Ravaioli, V. Abbasciano, Lorenzo Gianni, G. Drudi, D. Iorio, E. Pasquini
Publikováno v:
Annals of Oncology. 8:1263-1267
Several antineoplastic drugs are known to have cardiactoxic effects [1-4] which may be dose-limiting, and whichrange over a wide spectrum of cardiac pathology, in-cluding cardiomyopathy, ischaemia and arrhythmia [1].Supraventricular and ventricular a
Autor:
V. Arcangeli, Carlotta Santelmo, M. Famtini, A. Polselli, Emiliano Tamburini, Stefania Nicoletti, Lorenzo Gianni, G. Drudi, M. Nicolini, L. Stocchi, Davide Tassinari, E. Barzotti, Claudio Ridolfi, Fabrizio Drudi
Publikováno v:
Annals of Oncology. 27:iv120
Autor:
Davide Tassinari, Manuela Fantini, V. Arcangeli, A. Affatato, A. Polselli, L. Stocchi, B. Venturini, Emiliano Tamburini, M. Nicolini, G. Drudi, E. Barzotti
Publikováno v:
Annals of Oncology. 26:vi50
Autor:
Emiliano Tamburini, Ilaria Panzini, A. Ravaioli, G. Drudi, F. Desiderio, E. Pini, Lorenzo Gianni, Britt Rudnas, Davide Tassinari
Publikováno v:
Annals of Oncology. 26:vi25
Autor:
Daniele Turci, Luigi Gallo, Silvio Monfardini, Paolo Giordani, Roberto Bandelloni, Vincenzo Catalano, Sandro Barni, Domizia Debernardis, Carlo Aschele, Sara Lonardi, G. Drudi, Stefano Cascinu, F. Maley
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 13(12)
Background Different 5-fluorouracil (5-FU) schedules and/or biochemical modulators may resultin different mechanisms of cytotoxicity, potentially affecting the correlation between thymidylate synthase (TS) expression and the clinical response to the
Autor:
V. Arcangeli, G. Drudi, G. Oliverio, E. Pasquini, Alberto Ravaioli, Lorenzo Gianni, G. Pasini, Ilaria Panzini, S. Sartori, A. M. Mianulli, F. Fochessati, Davide Tassinari
Publikováno v:
International journal of clinical oncology. 6(6)
Background. Some trials have suggested that the combination of gemcitabine and platinum compounds can have a synergistic effect on several solid tumors, but, at present, the data concerning carboplatin-gemcitabine combinations are not sufficient to a